The dawn of a new era in retinal therapeutics arrives with ENCELTO FDA approval, marking an extraordinary scientific achievement that transforms macular telangiectasia type 2 (MacTel) from an untreatable condition into a manageable disease. This groundbreaking approval by Neurotech represents the culmination of innovative research and offers unprecedented hope to patients worldwide who have struggled… Read.